MedPath
NMPA Approval

Cefaclor for Suspension

国药准字H20243732

May 21, 2024

Drug Information

头孢克洛干混悬剂

口服混悬剂

0.125g(按C₁₅H₁₄ClN₃O₄S计)

化学药品

May 21, 2024

Company Information

Applicant Company

苏州市吴江区汾湖高新技术产业开发区金字路8号

Manufacturing Company

苏州市吴江区汾湖高新技术产业开发区金字路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢克洛干混悬剂 - NMPA 批准文号 | MedPath